🇩🇪 SUGEMALIMAB in Germany

SUGEMALIMAB (SUGEMALIMAB) regulatory status in Germany.

Marketing authorisation

BfArM

  • Local brand name: Cejemly
  • Status: approved

SUGEMALIMAB in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in Germany

Frequently asked questions

Is SUGEMALIMAB approved in Germany?

Yes. BfArM has authorised it.

Who is the marketing authorisation holder for SUGEMALIMAB in Germany?

Marketing authorisation holder not available in our data.